JAK2-negative ET patients do not display constitutively active JAK/STAT signaling
- 1 November 2007
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 35 (11) , 1695-1703
- https://doi.org/10.1016/j.exphem.2007.07.004
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- Polycythemia vera is not initiated by JAK2 mutationExperimental Hematology, 2007
- Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraBlood, 2006
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLoS Medicine, 2006
- Update on Diagnosis and Management of Essential ThrombocythemiaSeminars in Thrombosis and Hemostasis, 2006
- Essential ThrombocythemiaSeminars in Hematology, 2005
- The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia veraBritish Journal of Haematology, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisPublished by Elsevier ,2005
- Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF‐E2British Journal of Haematology, 2005
- Stat3 regulates genes common to both wound healing and cancerOncogene, 2005